JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
MYGN Financials - Myriad Genetics Income & Cash Flow | Ledgeburg
MYGN - Myriad Genetics Inc.
USD | NASDAQ | Healthcare
Summary
Summary MYGN Stock
Financials
Financials MYGN Stock
Loading...
Loading...
Income Statement
Income Statement MYGN Stock
Balance Sheet
Balance Sheet MYGN Stock
Cash Flow Statement
Cash Flow Statement MYGN Stock
Loading...
Loading...
Home
Stocks
Myriad Genetics Inc. (MYGN)
Financials
Financials of MYGN
Loading...
Loading...
Loading...
Loading...
Revenue
$824.5M
Operating Income
$-387.2M
Net Income
$-365.9M
Share Count (Basic)
92.6M
Operating Cash Flow
$1.8M
Free Cash Flow
N/A
Cash And Short-Term Equivalents
$149.6M
Total Debt
$119.9M
Annual
Quarterly
Revenue $USD
0
200M
400M
600M
800M
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue $USD
0
50M
100M
150M
200M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Annual
Quarterly
Net Income $USD
-400M
-300M
-200M
-100M
0
Annual
Quarterly
Margins
Gross
Operating
Net
-50%
0%
50%
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-300M
-200M
-100M
0
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-150%
-100%
-50%
0%
50%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26